Insights & Publications

Insights

TriCore’s Phlebotomy Trainee Program: Fills a Critical Need

Background Running a business in New Mexico is challenging. Much of our talent, especially in STEM fields—science, technology, engineering, and mathematics—leaves the state and typically don’t return. This migration has created a shortage of qualified professionals, particularly in healthcare. Consequently, our academic centers struggle to produce enough graduates, especially in biosciences, to meet the needs…

Read More

Point of Care Testing: A Blessing or a Burden?

Point-of-care testing (POCT) refers to medical diagnostic testing that is performed near the patient, often at the bedside, rather than in a centralized laboratory. This type of testing provides rapid results, allowing healthcare providers to make immediate treatment decisions. POCT devices are typically portable, easy to use, and require minimal training. They are suitable for…

Read More

TriCore’s Mobile Testing Program Ties to its Mission

Monique Dodd, PharmD, PhC, MLS(ASCP)CM, TriCore’s Manager, Enterprise Clinical Solutions and Karissa Culbreath, PhD, D(ABMM) TriCore’s Chief Medical Director, Infectious Disease, were interviewed for this article.   The barriers to accessing healthcare is a major contributor to poor health outcomes and increased healthcare costs in the U.S. TriCore’s footprint across New Mexico has enabled improved…

Read More

The Basics of the FDA’s Proposed Rules for Laboratory Developed Tests

Overview David G. Grenache, PhD D(ABCC), TriCore’s Chief Scientific Officer, and Melissa M. Budelier, PhD D(ABCC), TriCore’s Medical Director of Clinical Chemistry and Toxicology, were interviewed for this article. On September 29, 2023, the Federal Drug Administration (FDA) proposed rules to regulate laboratory developed tests (LDT). These rules could significantly affect patient care and labs…

Read More

New Areas of Discovery and Collaboration

Since its inception, TriCore’s Research Institute has experienced steady and continuous growth, emphasizing research in the field of infectious diseases. During the pandemic, the focus was on COVID Emergency Use Authorizations, which were crucial. The Institute is now diversifying to encompass more intricate studies, such as more complex COVID 510(k) submissions and other respiratory viruses….

Read More